Immunosuppression and aberrant T cell development in the absence of N-myristoylation

Journal of Immunology

Volumn 195, Issue 9, 2015, Pages 4228-4243

  Rampoldi, Francesca ^a   Bonrouhi, Mahnaz ^a   Boehm, Martin E ^a   Lehmann, Wolf D ^a   Popovic, Zoran V ^a,b   Kaden, Sylvia ^a   Federico, Giuseppina ^a   Brunk, Fabian ^a   Gröne, Hermann Josef ^a   Porubsky, Stefan ^a,b  

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^b UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CD3 ANTIGEN; GAMMA INTERFERON; INTERLEUKIN 2; MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN KINASE ZAP 70; PROTEIN N MYRISTOYLTRANSFERASE; PROTEIN N MYRISTOYLTRANSFERASE 1; PROTEIN N MYRISTOYLTRANSFERASE 2; STAPHYLOCOCCUS ENTEROTOXIN B; T LYMPHOCYTE RECEPTOR; UNCLASSIFIED DRUG; ACYLTRANSFERASE; CD4 ANTIGEN; LYMPHOCYTE ANTIGEN RECEPTOR; MEMBRANE PROTEIN; MYRISTIC ACID; MYRISTOYLATED ALANINE-RICH C KINASE SUBSTRATE; N-MYRISTOYLTRANSFERASE, MOUSE; PROTEIN; PROTEIN KINASE LCK; SIGNAL PEPTIDE;

ANIMAL CELL; ARTICLE; CELL LINEAGE; CELL MATURATION; CONTROLLED STUDY; CPG ISLAND; ENZYME ACTIVITY; ENZYME LOCALIZATION; IMMUNOSUPPRESSIVE TREATMENT; IN VIVO STUDY; MOUSE; MYRISTYLATION; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; T LYMPHOCYTE; THYMOCYTE; ANIMAL; CELL CULTURE; DEFICIENCY; IMMUNOLOGICAL TOLERANCE; IMMUNOLOGY; METABOLISM; PHYSIOLOGY;

ACYLTRANSFERASES; ANIMALS; ANTIGENS, CD4; CELLS, CULTURED; IMMUNE TOLERANCE; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; LYMPHOCYTE SPECIFIC PROTEIN TYROSINE KINASE P56(LCK); MEMBRANE PROTEINS; MICE; MYRISTIC ACID; PROTEINS; RECEPTORS, ANTIGEN, T-CELL; T-LYMPHOCYTES;

EID: 84945151577     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1500622     Document Type: Article

References (57)

1. Ceredig, R., and T. Rolink. 2002. A positive look at double-negative thymocytes. Nat. Rev. Immunol. 2: 888-897.
2. Lind, E. F., S. E. Prockop, H. E. Porritt, and H. T. Petrie. 2001. Mapping precursor movement through the postnatal thymus reveals specific microenvironments supporting defined stages of early lymphoid development. J. Exp. Med. 194: 127-134.
3. - triple-negative adult mouse thymocytes defined by CD44 and CD25 expression. J. Immunol. 150: 4244-4252.
4. Germain, R. N. 2002. T-cell development and the CD4-CD8 lineage decision. Nat. Rev. Immunol. 2: 309-322.
5. Robey, E., and B. J. Fowlkes. 1994. Selective events in T cell development. Annu. Rev. Immunol. 12: 675-705.
6. Palacios, E. H., and A. Weiss. 2004. Function of the Src-family kinases, Lck and Fyn, in T-cell development and activation. Oncogene 23: 7990-8000.
7. Wilcox, C., J. S. Hu, and E. N. Olson. 1987. Acylation of proteins with myristic acid occurs cotranslationally. Science 238: 1275-1278.
8. Zha, J., S. Weiler, K. J. Oh, M. C. Wei, and S. J. Korsmeyer. 2000. Posttranslational N-myristoylation of BID as a molecular switch for targeting mitochondria and apoptosis. Science 290: 1761-1765.
9. Kamps, M. P., J. E. Buss, and B. M. Sefton. 1985. Mutation of NH2-terminal glycine of p60src prevents both myristoylation and morphological transformation. Proc. Natl. Acad. Sci. USA 82: 4625-4628.
10. Wright, M. H., W. P. Heal, D. J. Mann, and E. W. Tate. 2010. Protein myristoylation in health and disease. J. Chem. Biol. 3: 19-35.
11. Towler, D., and L. Glaser. 1986. Acylation of cellular proteins with endogenously synthesized fatty acids. Biochemistry 25: 878-884.
12. Giang, D. K., and B. F. Cravatt. 1998. A second mammalian N-myristoyltransferase. J. Biol. Chem. 273: 6595-6598.
13. Farazi, T. A., G. Waksman, and J. I. Gordon. 2001. The biology and enzymology of protein N-myristoylation. J. Biol. Chem. 276: 39501-39504.
14. Yang, S. H., A. Shrivastav, C. Kosinski, R. K. Sharma, M. H. Chen, L. G. Berthiaume, L. L. Peters, P. T. Chuang, S. G. Young, and M. O. Bergo. 2005. N-myristoyltransferase 1 is essential in early mouse development. J. Biol. Chem. 280: 18990-18995.
15. Rampoldi, F., R. Sandhoff, R. W. Owen, H. J. Gröne, and S. Porubsky. 2012. A new, robust, and nonradioactive approach for exploring N-myristoylation. J. Lipid Res. 53: 2459-2468.
16. Lee, P. P., D. R. Fitzpatrick, C. Beard, H. K. Jessup, S. Lehar, K. W. Makar, M. Pérez-Melgosa, M. T. Sweetser, M. S. Schlissel, S. Nguyen, et al. 2001. A critical role for Dnmt1 and DNA methylation in T cell development, function, and survival. Immunity 15: 763-774.
17. Muyrers, J. P., Y. Zhang, and A. F. Stewart. 2001. Techniques: recombinogenic engineering - new options for cloning and manipulating DNA. Trends Biochem. Sci. 26: 325-331.
18. Rodríguez, C. I., F. Buchholz, J. Galloway, R. Sequerra, J. Kasper, R. Ayala, A. F. Stewart, and S. M. Dymecki. 2000. High-efficiency deleter mice show that FLPe is an alternative to Cre-loxP. Nat. Genet. 25: 139-140.
19. Holden, P., and W. A. Horton. 2009. Crude subcellular fractionation of cultured mammalian cell lines. BMC Res. Notes 2: 243.
20. Tokuyasu, T. K. 1997. Immunocytochemistry on Ultrathin Cryosections. Cells: A Laboratory Manual. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY.
21. Raju, R. V., J. W. Anderson, R. S. Datla, and R. K. Sharma. 1997. Molecular cloning and biochemical characterization of bovine spleen myristoyl CoA:protein N-myristoyltransferase. Arch. Biochem. Biophys. 348: 134-142.
22. Sinclair, C., I. Bains, A. J. Yates, and B. Seddon. 2013. Asymmetric thymocyte death underlies the CD4:CD8 T-cell ratio in the adaptive immune system. Proc. Natl. Acad. Sci. USA 110: E2905-E2914.
23. Shi, J., and H. T. Petrie. 2012. Activation kinetics and off-target effects of thymus-initiated cre transgenes. PLoS One 7: e46590.
24. Azzam, H. S., A. Grinberg, K. Lui, H. Shen, E. W. Shores, and P. E. Love. 1998. CD5 expression is developmentally regulated by T cell receptor (TCR) signals and TCR avidity. J. Exp. Med. 188: 2301-2311.
25. Yamashita, I., T. Nagata, T. Tada, and T. Nakayama. 1993. CD69 cell surface expression identifies developing thymocytes which audition for T cell antigen receptor-mediated positive selection. Int. Immunol. 5: 1139-1150.
26. Kadlecek, T. A., N. S. van Oers, L. Lefrancois, S. Olson, D. Finlay, D. H. Chu, K. Connolly, N. Killeen, and A. Weiss. 1998. Differential requirements for ZAP-70 in TCR signaling and T cell development. J. Immunol. 161: 4688-4694.
27. Acuto, O., and F. Michel. 2003. CD28-mediated co-stimulation: a quantitative support for TCR signalling. Nat. Rev. Immunol. 3: 939-951.
28. Johnson, D. R., R. S. Bhatnagar, L. J. Knoll, and J. I. Gordon. 1994. Genetic and biochemical studies of protein N-myristoylation. Annu. Rev. Biochem. 63: 869-914.
29. Vergères, G., and J. J. Ramsden. 1998. Binding of MARCKS (myristoylated alanine-rich C kinase substrate)-related protein (MRP) to vesicular phospholipid membranes. Biochem. J. 330: 5-11.
30. Miethke, T., C. Wahl, K. Heeg, B. Echtenacher, P. H. Krammer, and H. Wagner. 1992. T cell-mediated lethal shock triggered in mice by the superantigen staphylococcal enterotoxin B: critical role of tumor necrosis factor. J. Exp. Med. 175: 91-98.
31. Johnson, D. R., S. J. Cok, H. Feldmann, and J. I. Gordon. 1994. Suppressors of nmtl-181, a conditional lethal allele of the Saccharomyces cerevisiae myristoyl-CoA:protein N-myristoyltransferase gene, reveal proteins involved in regulating protein N-myristoylation. Proc. Natl. Acad. Sci. USA 91: 10158-10162.
32. Ntwasa, M., S. Aapies, D. A. Schiffmann, and N. J. Gay. 2001. Drosophila embryos lacking N-myristoyltransferase have multiple developmental defects. Exp. Cell Res. 262: 134-144.
33. Shrivastav, A., S. Varma, Z. Lawman, S. H. Yang, S. A. Ritchie, K. Bonham, S. M. Singh, A. Saxena, and R. K. Sharma. 2008. Requirement of N-myristoyltransferase 1 in the development of monocytic lineage. J. Immunol. 180: 1019-1028.
34. Jameson, S. C. 2002. Maintaining the norm: T-cell homeostasis. Nat. Rev. Immunol. 2: 547-556.
35. Surh, C. D., B. Ernst, and J. Sprent. 1992. Growth of epithelial cells in the thymic medulla is under the control of mature T cells. J. Exp. Med. 176: 611-616.
36. + T cell tolerance. Nat. Immunol. 11: 512-519.
37. White, A. J., K. Nakamura, W. E. Jenkinson, M. Saini, C. Sinclair, B. Seddon, P. Narendran, K. Pfeffer, T. Nitta, Y. Takahama, et al. 2010. Lymphotoxin signals from positively selected thymocytes regulate the terminal differentiation of medullary thymic epithelial cells. J. Immunol. 185: 4769-4776.
38. Resh, M. D. 1994. Myristylation and palmitylation of Src family members: the fats of the matter. Cell 76: 411-413.
39. lck with cytoplasmic domains of CD4 and CD8 is mediated by cysteine motifs. Cell 60: 755-765.
40. Zlatkine, P., B. Mehul, and A. I. Magee. 1997. Retargeting of cytosolic proteins to the plasma membrane by the Lck protein tyrosine kinase dual acylation motif. J. Cell Sci. 110: 673-679.
41. Yasuda, K., A. Kosugi, F. Hayashi, S. Saitoh, M. Nagafuku, Y. Mori, M. Ogata, and T. Hamaoka. 2000. Serine 6 of Lck tyrosine kinase: a critical site for Lck myristoylation, membrane localization, and function in T lymphocytes. J. Immunol. 165: 3226-3231.
42. lck. J. Biol. Chem. 268: 8669-8674.
43. Kabouridis, P. S., A. I. Magee, and S. C. Ley. 1997. S-acylation of LCK protein tyrosine kinase is essential for its signalling function in T lymphocytes. EMBO J. 16: 4983-4998.
44. van Oers, N. S., B. Lowin-Kropf, D. Finlay, K. Connolly, and A. Weiss. 1996. αβ T cell development is abolished in mice lacking both Lck and Fyn protein tyrosine kinases. Immunity 5: 429-436.
45. lck travels to the plasma membrane via the exocytic pathway. J. Cell Biol. 145: 457-468.
46. Tuosto, L., I. Parolini, S. Schröder, M. Sargiacomo, A. Lanzavecchia, and A. Viola. 2001. Organization of plasma membrane functional rafts upon T cell activation. Eur. J. Immunol. 31: 345-349.
47. Ehrlich, L. I., P. J. Ebert, M. F. Krummel, A. Weiss, and M. M. Davis. 2002. Dynamics of p56lck translocation to the T cell immunological synapse following agonist and antagonist stimulation. Immunity 17: 809-822.
48. Aderem, A. 1992. The MARCKS brothers: a family of protein kinase C substrates. Cell 71: 713-716.
49. Hartwig, J. H., M. Thelen, A. Rosen, P. A. Janmey, A. C. Nairn, and A. Aderem. 1992. MARCKS is an actin filament crosslinking protein regulated by protein kinase C and calcium-calmodulin. Nature 356: 618-622.
50. Arbuzova, A., A. A. Schmitz, and G. Vergères. 2002. Cross-talk unfolded: MARCKS proteins. Biochem. J. 362: 1-12.
51. McLaughlin, S., and A. Aderem. 1995. The myristoyl-electrostatic switch: a modulator of reversible protein-membrane interactions. Trends Biochem. Sci. 20: 272-276.
52. Seykora, J. T., M. M. Myat, L. A. Allen, J. V. Ravetch, and A. Aderem. 1996. Molecular determinants of the myristoyl-electrostatic switch of MARCKS. J. Biol. Chem. 271: 18797-18802.
53. Price, H. P., M. R. Menon, C. Panethymitaki, D. Goulding, P. G. McKean, and D. F. Smith. 2003. Myristoyl-CoA:protein N-myristoyltransferase, an essential enzyme and potential drug target in kinetoplastid parasites. J. Biol. Chem. 278: 7206-7214.
54. Lodge, J. K., E. Jackson-Machelski, D. L. Toffaletti, J. R. Perfect, and J. I. Gordon. 1994. Targeted gene replacement demonstrates that myristoyl-CoA: protein N-myristoyltransferase is essential for viability of Cryptococcus neoformans. Proc. Natl. Acad. Sci. USA 91: 12008-12012.
55. Maurer-Stroh, S., and F. Eisenhaber. 2004. Myristoylation of viral and bacterial proteins. Trends Microbiol. 12: 178-185.
56. Frearson, J. A., S. Brand, S. P. McElroy, L. A. Cleghorn, O. Smid, L. Stojanovski, H. P. Price, M. L. Guther, L. S. Torrie, D. A. Robinson, et al. 2010. N-myristoyltransferase inhibitors as new leads to treat sleeping sickness. Nature 464: 728-732.
57. Bhandarkar, S. S., J. Bromberg, C. Carrillo, P. Selvakumar, R. K. Sharma, B. N. Perry, B. Govindarajan, L. Fried, A. Sohn, K. Reddy, and J. L. Arbiser. 2008. Tris (dibenzylideneacetone) dipalladium, a N-myristoyltransferase-1 inhibitor, is effective against melanoma growth in vitro and in vivo. Clin. Cancer Res. 14: 5743-5748.